480 related articles for article (PubMed ID: 25004111)
21. Hymenoptera venom allergy.
Ebo DG
Verh K Acad Geneeskd Belg; 2007; 69(4):213-30. PubMed ID: 17821959
[TBL] [Abstract][Full Text] [Related]
22. A simple 3-day "rush" venom immunotherapy protocol: documentation of safety.
Kalogeromitros D; Makris M; Koti I; Chliva C; Mellios A; Avgerinou G; Theoharides TC
Allergol Immunopathol (Madr); 2010; 38(2):69-73. PubMed ID: 19853357
[TBL] [Abstract][Full Text] [Related]
23. Insect Venom Immunotherapy: Analysis of the Safety and Tolerance of 3 Buildup Protocols Frequently Used in Spain.
Gutiérrez Fernández D; Moreno-Ancillo A; Fernández Meléndez S; Domínguez-Noche C; Gálvez Ruiz P; Alfaya Arias T; Carballada González F; Alonso Llamazares A; Marques Amat L; Vega Castro A; Antolín Amérigo D; Cruz Granados S; Ruiz León B; Sánchez Morillas L; Fernández Sánchez J; Soriano Gomis V; Borja Segade J; Dalmau Duch G; Guspi Bori R; Miranda Páez A
J Investig Allergol Clin Immunol; 2016; 26(6):366-373. PubMed ID: 27996943
[TBL] [Abstract][Full Text] [Related]
24. Epidemiology, diagnosis, and treatment of Hymenoptera venom allergy in mastocytosis patients.
Niedoszytko M; Bonadonna P; Oude Elberink JN; Golden DB
Immunol Allergy Clin North Am; 2014 May; 34(2):365-81. PubMed ID: 24745680
[TBL] [Abstract][Full Text] [Related]
25. Functional Profile of Antigen Specific CD4
Fernandes LGR; Perez-Riverol A; Bazon ML; Abram DM; Brochetto-Braga MR; Zollner RL
Toxins (Basel); 2020 Jun; 12(6):. PubMed ID: 32521656
[TBL] [Abstract][Full Text] [Related]
26. Pregnancy and Hymenoptera venom allergy.
Bonadonna P; Mauro M; Preziosi D; Pravettoni V
Curr Opin Allergy Clin Immunol; 2020 Oct; 20(5):465-469. PubMed ID: 32769711
[TBL] [Abstract][Full Text] [Related]
27. Stinging insect allergy: state of the art 2015.
Tankersley MS; Ledford DK
J Allergy Clin Immunol Pract; 2015; 3(3):315-22; quiz 323. PubMed ID: 25956310
[TBL] [Abstract][Full Text] [Related]
28. Regulatory T cells in children undergoing rush venom immunotherapy.
Ajduk J; Turkalj M; Gagro A
Allergy Asthma Proc; 2012; 33(6):525-30. PubMed ID: 23394512
[TBL] [Abstract][Full Text] [Related]
29. Patients still reacting to a sting challenge while receiving conventional Hymenoptera venom immunotherapy are protected by increased venom doses.
Ruëff F; Wenderoth A; Przybilla B
J Allergy Clin Immunol; 2001 Dec; 108(6):1027-32. PubMed ID: 11742283
[TBL] [Abstract][Full Text] [Related]
30. Hymenoptera venom allergy in humans.
Cichocka-Jarosz E
Folia Med Cracov; 2012; 52(3-4):43-60. PubMed ID: 24852686
[TBL] [Abstract][Full Text] [Related]
31. Ultra-rush venom immunotherapy induces differential T cell activation and regulatory patterns according to the severity of allergy.
Mamessier E; Birnbaum J; Dupuy P; Vervloet D; Magnan A
Clin Exp Allergy; 2006 Jun; 36(6):704-13. PubMed ID: 16776670
[TBL] [Abstract][Full Text] [Related]
32. Diagnosis of Hymenoptera venom allergy.
Biló BM; Rueff F; Mosbech H; Bonifazi F; Oude-Elberink JN;
Allergy; 2005 Nov; 60(11):1339-49. PubMed ID: 16197464
[TBL] [Abstract][Full Text] [Related]
33. The adhesion molecule ICAM-1 is overexpressed in patients with Hymenoptera venom allergy and decreases after ultrarush venom immunotherapy.
Patella V; Incorvaia C; Ricciardi L; Florio G; Saija A; Frati F; Gangemi S
J Biol Regul Homeost Agents; 2011; 25(3):465-8. PubMed ID: 22023772
[TBL] [Abstract][Full Text] [Related]
34. Basophil response and the induction of a tolerance in venom immunotherapy: a long-term sting challenge study.
Eržen R; Košnik M; Silar M; Korošec P
Allergy; 2012 Jun; 67(6):822-30. PubMed ID: 22469017
[TBL] [Abstract][Full Text] [Related]
35. Hymenoptera Venom Allergy: How Does Venom Immunotherapy Prevent Anaphylaxis From Bee and Wasp Stings?
Sahiner UM; Durham SR
Front Immunol; 2019; 10():1959. PubMed ID: 31497015
[TBL] [Abstract][Full Text] [Related]
36. A 'difficult' insect allergy patient: reliable history of a sting, but all testing negative.
Tracy JM; Olsen JA; Carlson J
Curr Opin Allergy Clin Immunol; 2015 Aug; 15(4):358-63. PubMed ID: 26110687
[TBL] [Abstract][Full Text] [Related]
37. Deliberate hymenoptera sting challenge as a diagnostic tool in highly selected venom-allergic patients.
Goldberg A; Confino-Cohen R; Mekori YA
Ann Allergy Asthma Immunol; 1995 Jul; 75(1):30-2. PubMed ID: 7621057
[TBL] [Abstract][Full Text] [Related]
38. Age-dependent sting recurrence and outcome in immunotherapy-treated children with anaphylaxis to Hymenoptera venom.
Stritzke AI; Eng PA
Clin Exp Allergy; 2013 Aug; 43(8):950-5. PubMed ID: 23889248
[TBL] [Abstract][Full Text] [Related]
39. Predictors of side effects during the buildup phase of venom immunotherapy for Hymenoptera venom allergy: the importance of baseline serum tryptase.
Ruëff F; Przybilla B; Biló MB; Müller U; Scheipl F; Aberer W; Birnbaum J; Bodzenta-Lukaszyk A; Bonifazi F; Bucher C; Campi P; Darsow U; Egger C; Haeberli G; Hawranek T; Kucharewicz I; Küchenhoff H; Lang R; Quercia O; Reider N; Severino M; Sticherling M; Sturm GJ; Wüthrich B;
J Allergy Clin Immunol; 2010 Jul; 126(1):105-11.e5. PubMed ID: 20542320
[TBL] [Abstract][Full Text] [Related]
40. Mastocytosis and insect venom allergy.
Bonadonna P; Zanotti R; Müller U
Curr Opin Allergy Clin Immunol; 2010 Aug; 10(4):347-53. PubMed ID: 20485157
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
